 |
| |
|
A growing body of evidence demonstrates misoprostol can be used safely and effectively to terminate an unwanted pregnancy. As important, this evidence also shows misoprostol can be used safely and effectively by women in nonclinic settings – an important consideration given limitations on women’s access to safe abortion as well as quality of abortion services worldwide.
In July 2003, Gynuity Health Projects and the Reproductive Health Technologies Project convened a group of professionals with epidemiological, clinical and programmatic expertise in use of misoprostol for early pregnancy termination to develop consensus guidelines on this indication.
Download:
- Instructions for Use: Misoprostol for the Termination of Pregnancy up to 9 weeks LMP – Consensus Guidelines
- Instructions for Use: Misoprostol for the Termination of Pregnancy up to 9 weeks LMP – Annotated Bibliography [PDF, 43KB]
|
|
|
| |
|
|
Consensus Guidelines: Misoprostol for the Treatment of Incomplete Abortion and Miscarriage
|
|
Gynuity Health Projects
Gynuity Health Projects is a research and technical assistance organization dedicated to the idea that all people should have access to the fruits of medical science and technology development.
|
Misoprostol: An Emerging Technology for Women's Health [PDF, 565KB]
The report highlights the potential of misoprostol to improve women’s health. The meeting summarized in this report was organized because a large body of scientific work supporting the use of misoprostol for induced abortion, uterine evacuation after pregnancy failure, cervical priming, labor induction, and management of the third stage of labor, had not been synthesized in an accessible way.
|
|
|
|
|
